Literature DB >> 8933230

Progressive multifocal leukoencephalopathy during cyclosporine treatment. A case report.

S Gentile1, I Sacerdote, D Roccatello, M T Giordana.   

Abstract

A 45-year-old patient suffering from chronic renal insufficiency developed dermatopolymyositis. Since the patient did not respond to treatment with high doses of prednisone and immunoglobulin, concomitant cyclosporine A was added. Four months later, worsening signs of bilateral pyramidal disorder and an altered state of consciousness appeared. Serial computed tomography (CT) and magnetic resonance imaging (MRI) revealed multiple alterations of the cerebral white matter. Cyclosporine was then discontinued. One month later, exitus occurred. Microscopic examination of the brain showed diffuse tumescence; histological examination revealed perivascular and diffuse lymphomonocyte infiltrations, areas of demyelination, astrocytes with bizarre nuclei, and oligodendrocytes with enlarged nuclei due to hyperchromatic inclusion. Morphological examination confirmed the presence of intranuclear icosahedral viral bodies. Progressive multifocal leukoencephalopathy was diagnosed. The literature contains only one report of an analogous case observed during a course of cyclosporine treatment for Wegener's granulomatosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933230     DOI: 10.1007/bf01999899

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  18 in total

1.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

2.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

3.  Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients.

Authors:  B F Palmer; R D Toto
Journal:  Am J Kidney Dis       Date:  1991-07       Impact factor: 8.860

4.  Electron microscopic observations on a case of progressive multifocal leukoencephalopathy.

Authors:  L Silverman; L J Rubinstein
Journal:  Acta Neuropathol       Date:  1965-11-18       Impact factor: 17.088

5.  Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

Authors:  P Cherin; S Herson; B Wechsler; J C Piette; O Bletry; A Coutellier; J M Ziza; P Godeau
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

6.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

Review 7.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

8.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

9.  [Progressive multifocal leukoencephalopathy in Wegener's granulomatosis in relation to therapy with cyclosporin A].

Authors:  J Ettinger; W Feiden; G Hübner; M Schreiner
Journal:  Klin Wochenschr       Date:  1989-02-15

10.  The use of intravenous immune globulin in collagen vascular disorders: a potentially new modality of therapy.

Authors:  E W Gelfand
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

View more
  5 in total

Review 1.  Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature.

Authors:  K Warnatz; H H Peter; M Schumacher; L Wiese; A Prasse; F Petschner; P Vaith; B Volk; S M Weiner
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  [Nervous system side effects of disease modifying treatments of rheumatoid arthritis].

Authors:  A Rubbert-Roth; H-F Petereit
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

3.  Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.

Authors:  S Vulliemoz; F Lurati-Ruiz; F-X Borruat; J Delavelle; I J Koralnik; T Kuntzer; J Bogousslavsky; F Picard; T Landis; R A Du Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

4.  JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis.

Authors:  Nana Merabova; Dorota Kaniowska; Rafal Kaminski; Satish L Deshmane; Martyn K White; Shohreh Amini; Armine Darbinyan; Kamel Khalili
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

5.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.